Medicare Enrolled
Dr. Sven Wenske, MD
Urology Physician · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wenske from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wenske?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wenske
Dr. Sven Wenske is an urology physician in New York, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Wenske performed 2,481 Medicare services across 1,800 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wenske received a total of $3,489 from 24 pharmaceutical and/or device companies across 52 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wenske is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 29% volume in NY
$3,489 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,481
Medicare services
Top 29% in NY for urology physician
1,800
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~146 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
648 | $10 | $77 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
621 | $106 | $411 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
169 | $135 | $635 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
114 | $216 | $808 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
103 | $73 | $273 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 94 | $131 | $553 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
67 | $161 | $557 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
65 | $111 | $394 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
61 | $75 | $277 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
53 | $8 | $13 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
49 | $226 | $858 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
48 | $131 | $364 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
41 | $72 | $329 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
41 | $157 | $771 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
40 | $95 | $422 |
| Insertion of temporary bladder tube | 34 | $42 | $214 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
34 | $30 | $127 |
| Complicated insertion of bladder tube | 24 | $146 | $511 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
21 | $132 | $1,931 |
| New patient office visit, complex (60-74 min) | 20 | $193 | $797 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
19 | $640 | $7,229 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
17 | $22 | $68 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
16 | $7 | $63 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
15 | $358 | $1,234 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
15 | $189 | $812 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
14 | $31 | $757 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $380 | $1,642 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
12 | $142 | $14,856 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
12 | $50 | $532 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
33.1% medium
65.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,489
Total received (2018-2024)
Avg $498/year across 7 years
Top 40% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
52
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,310 (66.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,096 (31.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$83 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$833
2023
$33
2022
$298
2021
$100
2020
$1,714
2019
$214
2018
$298
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
LEICA MICROSYSTEMS INC.
$450
Sentynl Therapeutics, Inc.
$300
C. R. Bard, Inc. & Subsidiaries
$83
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Scientific Affairs, LLC
$1,560
LEICA MICROSYSTEMS INC.
$450
Sentynl Therapeutics, Inc.
$300
Astellas Pharma US Inc
$272
EDAP TECHNOMED INC
$133
C. R. Bard, Inc. & Subsidiaries
$83
UROVANT SCIENCES INC
$77
Photocure Inc
$73
Janssen Biotech, Inc.
$67
Palette Life Sciences, Inc.
$65
MEDIVATION FIELD SOLUTIONS LLC
$63
TOLMAR Pharmaceuticals, Inc.
$53
180 Medical, Inc.
$41
Myovant Sciences Inc.
$40
Hollister Incorporated
$33
AbbVie Inc.
$32
Coloplast Corp
$28
Blue Earth Diagnostics Limited
$22
PFIZER INC.
$20
BOSTON SCIENTIFIC CORPORATION
$17
Merck Sharp & Dohme Corporation
$17
Antares Pharma, Inc.
$15
Avadel Specialty Pharmaceuticals, LLC
$13
AbbVie, Inc.
$13
Top 3 companies account for 66.2% of all-time payments
Associated products mentioned in payments ›
Axumin · Cysview · Deflux · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL KIDNEY STONE DISEASE · KEYTRUDA · LUPRON DEPOT · Lupron · MYRBETRIQ · Myrbetriq · Noctiva · ORGOVYX · Otrexup · SELF-CATH · SPEEDICATH · TOVIAZ · VaPro · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (66%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Urology physicians within 10 mi
751
Per 100K population
46.1
County median income
$104,553
Nearest hospital
NEW YORK STATE PSYCHIATRIC INSTITUTE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wenske is a clinical cardiology specialist, with above-average Medicare volume (top 29% in NY), with consulting-driven industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wenske experienced with bladder ultrasound after voiding?
Based on Medicare claims data, Dr. Wenske performed 648 bladder ultrasound after voiding services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wenske receive payments from pharmaceutical companies?
Yes. Dr. Wenske received a total of $3,489 from 24 companies across 52 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wenske's costs compare to other urology physicians in New York?
Dr. Wenske's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wenske) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in New York
Browse urology physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
LEICA MICROSYSTEMS INC. Payments to Doctors
See all physicians who received payments from LEICA MICROSYSTEMS INC.
By company
Sentynl Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Sentynl Therapeutics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology